IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,655 | -31.3% | 16,060 | -24.0% | 0.00% | – |
| Q2 2023 | $224,969 | -43.7% | 21,144 | -44.3% | 0.00% | – |
| Q1 2023 | $399,554 | +67.6% | 37,980 | +97.4% | 0.00% | – |
| Q4 2022 | $238,359 | -76.9% | 19,238 | -80.7% | 0.00% | – |
| Q3 2022 | $1,031,000 | +242.5% | 99,485 | +280.4% | 0.00% | – |
| Q2 2022 | $301,000 | -43.8% | 26,150 | -38.6% | 0.00% | – |
| Q1 2022 | $536,000 | +688.2% | 42,593 | +627.2% | 0.00% | – |
| Q4 2021 | $68,000 | -17.1% | 5,857 | -6.2% | 0.00% | – |
| Q3 2021 | $82,000 | -4.7% | 6,244 | -6.2% | 0.00% | – |
| Q2 2021 | $86,000 | -97.4% | 6,656 | -97.7% | 0.00% | – |
| Q1 2021 | $3,258,000 | -78.0% | 291,483 | -77.6% | 0.00% | -100.0% |
| Q4 2020 | $14,817,000 | -57.0% | 1,300,888 | -66.1% | 0.00% | -66.7% |
| Q3 2020 | $34,490,000 | -39.5% | 3,834,396 | -30.5% | 0.00% | -50.0% |
| Q2 2020 | $56,976,000 | -48.9% | 5,520,958 | -50.1% | 0.01% | -60.0% |
| Q1 2020 | $111,562,000 | -22.4% | 11,056,713 | +2.3% | 0.02% | -6.2% |
| Q4 2019 | $143,815,000 | +46.7% | 10,804,989 | -5.4% | 0.02% | +33.3% |
| Q3 2019 | $98,053,000 | -35.2% | 11,421,428 | -17.4% | 0.01% | -33.3% |
| Q2 2019 | $151,267,000 | -23.3% | 13,826,974 | -5.2% | 0.02% | -25.0% |
| Q1 2019 | $197,340,000 | +30.3% | 14,585,319 | -0.2% | 0.02% | +14.3% |
| Q4 2018 | $151,422,000 | -51.5% | 14,616,002 | -13.6% | 0.02% | -40.0% |
| Q3 2018 | $312,251,000 | -9.7% | 16,914,985 | -6.5% | 0.04% | -12.5% |
| Q2 2018 | $345,852,000 | +27.8% | 18,088,500 | +3.1% | 0.04% | +25.0% |
| Q1 2018 | $270,655,000 | +2.3% | 17,540,776 | -0.6% | 0.03% | +3.2% |
| Q4 2017 | $264,512,000 | -9.5% | 17,645,933 | -4.8% | 0.03% | -11.4% |
| Q3 2017 | $292,161,000 | -17.3% | 18,526,427 | -1.0% | 0.04% | -20.5% |
| Q2 2017 | $353,306,000 | +6.9% | 18,713,264 | -3.4% | 0.04% | +4.8% |
| Q1 2017 | $330,603,000 | +9.9% | 19,378,846 | -1.5% | 0.04% | +5.0% |
| Q4 2016 | $300,818,000 | -2.8% | 19,674,160 | +0.9% | 0.04% | -2.4% |
| Q3 2016 | $309,502,000 | +22.8% | 19,490,004 | +1.1% | 0.04% | +20.6% |
| Q2 2016 | $251,977,000 | +20.5% | 19,271,669 | +0.8% | 0.03% | +17.2% |
| Q1 2016 | $209,152,000 | -6.8% | 19,118,089 | -1.3% | 0.03% | -3.3% |
| Q4 2015 | $224,525,000 | +10.8% | 19,372,317 | -0.4% | 0.03% | +3.4% |
| Q3 2015 | $202,577,000 | -14.9% | 19,441,117 | -1.5% | 0.03% | -6.5% |
| Q2 2015 | $238,100,000 | -24.7% | 19,742,935 | -0.1% | 0.03% | -22.5% |
| Q1 2015 | $316,095,000 | +4.4% | 19,755,935 | 0.0% | 0.04% | +2.6% |
| Q4 2014 | $302,661,000 | +18.2% | 19,755,935 | -0.1% | 0.04% | +11.4% |
| Q3 2014 | $256,070,000 | -15.5% | 19,766,906 | 0.0% | 0.04% | -14.6% |
| Q2 2014 | $302,990,000 | +24.4% | 19,766,906 | 0.0% | 0.04% | +20.6% |
| Q1 2014 | $243,524,000 | +41.0% | 19,766,906 | +32.8% | 0.03% | +41.7% |
| Q4 2013 | $172,770,000 | -1.9% | 14,881,153 | +0.1% | 0.02% | -11.1% |
| Q3 2013 | $176,172,000 | +20.5% | 14,866,853 | +1.2% | 0.03% | +12.5% |
| Q2 2013 | $146,171,000 | – | 14,690,553 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |